ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 112 filers reported holding ACCELERON PHARMA INC in Q3 2015. The put-call ratio across all filers is 2.48 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $291,000 | -81.7% | 6,000 | -87.2% | 0.02% | -73.8% |
| Q2 2016 | $1,593,000 | -5.9% | 46,863 | -12.4% | 0.06% | +85.7% |
| Q2 2015 | $1,693,000 | -25.9% | 53,500 | -10.8% | 0.04% | -25.5% |
| Q1 2015 | $2,284,000 | -41.1% | 60,000 | -39.8% | 0.05% | -28.8% |
| Q4 2014 | $3,880,000 | – | 99,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |